tiprankstipranks
Trending News
More News >

Michael Aaron Kelly Insider Profile

4 Followers
Michael Aaron Kelly, Director at Hookipa Pharma, holds 31.07K shares in DMC Global (Ticker: BOOM), holds 31.75K shares in NeoGenomics (Ticker: NEO), holds 52.05K shares in Amicus (Ticker: FOLD).
tipranks
Michael Aaron Kelly

Michael Aaron Kelly
Hookipa Pharma (HOOK)
Director

Not Ranked
Michael Aaron Kelly has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
43.66%
30.36%
24.27%
1.02%
0.69% Others
A breakdown of Michael Aaron Kelly's holdings

Insider Roles

Amicus
(FOLD)
Director
NeoGenomics
(NEO)
Director
DMC Global
(BOOM)
Director
Aprea Therapeutics
(APRE)
Director
+2 other positions
Roles that Michael Aaron Kelly holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Michael Aaron Kelly

Michael Aaron Kelly's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Hookipa Pharma
Oct 23, 2020
Director
Uninformative Buy
$7.31K
DMC Global
Feb 27, 2025
Director
Uninformative Buy
$256.35K
NeoGenomics
Aug 13, 2024
Director
Uninformative Buy
187.61K
$320.73K
Aprea Therapeutics
Jul 01, 2021
Director
Uninformative Buy
$10.74K
Amicus
Jun 07, 2024
Director
Uninformative Buy
$461.20K
Prime Medicine, Inc.
Director
List of latest transactions for each holding click on a transaction to see Michael Aaron Kelly's performance on stock

Michael Aaron Kelly insider profile FAQ

What is the percentage of profitable transactions made by Michael Aaron Kelly?
The percentage of profitable transactions made by Michael Aaron Kelly is ―.
    What is the average return per transaction made by Michael Aaron Kelly?
    The average return per transaction made by Michael Aaron Kelly is ―.
      What stocks does Michael Aaron Kelly hold?
      Michael Aaron Kelly holds: HOOK, BOOM, NEO, APRE, FOLD, PRME stocks.
        What was Michael Aaron Kelly’s latest transaction?
        Michael Aaron Kelly latest transaction was an Uninformative Buy of ―.
          What was Michael Aaron Kelly's most profitable transaction?
          Michael Aaron Kelly’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Michael Aaron Kelly's role in Hookipa Pharma?
            Michael Aaron Kelly's role in Hookipa Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.